Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Identifies 18 Drug Targets for Bayer

Premium

CAMBRIDGE, Mass.--Millennium Pharmaceuticals and Bayer announced that they have identified 18 novel drug targets and moved four of them into high-throughput screening in less than eight months. In the collaboration, which is taking a production-oriented approach based on genomics research to move compounds toward clinical trials, targets were identified and validated by Millennium and are being screened by Bayer.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.